REGENEREX PHARMA, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Regenerex Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q4 2024.
  • Regenerex Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$315K, a 19.1% decline year-over-year.
  • Regenerex Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$1.41M, a 57.3% increase year-over-year.
  • Regenerex Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.54M, a 2481% decline from 2022.
  • Regenerex Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$137K, a 29.8% increase from 2021.
  • Regenerex Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$196K, a 44.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$1.41M -$315K -$50.6K -19.1% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-07
Q3 2024 -$1.36M -$530K +$2.27M +81.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$3.63M -$273K -$87K -46.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-04
Q1 2024 -$3.54M -$293K -$247K -533% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-24
Q4 2023 -$3.3M -$264K -$215K -434% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-07
Q3 2023 -$3.08M -$2.8M -$2.78M -15096% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$300K -$186K -$162K -700% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-04
Q1 2023 -$137K -$46.3K +$2.16K +4.46% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-24
Q4 2022 -$139K -$49.4K +$30K +37.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-05
Q3 2022 -$170K -$18.4K +$15.3K +45.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$185K -$23.2K +$10.7K +31.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$196K -$48.4K +$236K +83% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-09
Q4 2021 -$432K -$79.4K -$45.8K -136% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-24
Q3 2021 -$386K -$33.8K -$7.99K -31% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$378K -$34K -$24.1K -246% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$354K -$284K -$467K -256% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 $114K -$33.7K -$13.1K -63.9% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-02-03
Q3 2020 $127K -$25.8K -$7.3K -39.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $134K -$9.82K +$22.5K +69.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-01
Q1 2020 $112K $183K +$199K Jan 1, 2020 Mar 31, 2020 10-K 2021-06-23
Q4 2019 -$87.7K -$20.6K +$33.2K +61.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$121K -$18.5K -$13.7K -284% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$107K -$32.3K -$13.7K -73.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$93.6K -$16.5K -$2.45K -17.5% Jan 1, 2019 Mar 31, 2019 10-K/A 2020-08-11
Q4 2018 -$91.1K -$53.7K -$43.3K -415% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$47.8K -$4.81K +$3.32K +40.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$51.1K -$18.6K -$1.47K -8.6% Apr 1, 2018 Jun 30, 2018 10-Q/A 2019-07-29
Q1 2018 -$49.7K -$14K -$5.87K -72.3% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-24
Q4 2017 -$43.8K -$10.4K -$8.23K -372% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-04
Q3 2017 -$35.6K -$8.13K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$17.1K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$8.13K -$8.11K Jan 1, 2017 Mar 31, 2017 10-Q 2017-11-07
Q4 2016 -$2.21K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q1 2016 -$21* Jan 1, 2016 Mar 31, 2016 10-Q 2017-11-07
Q4 2014 $860K -$52.7K +$202K +79.3% Sep 1, 2014 Nov 30, 2014 10-K 2015-03-03
Q3 2014 $658K -$59.1K +$189K +76.2% Jun 1, 2014 Aug 31, 2014 10-Q 2014-10-20
Q2 2014 $469K $1.14M +$1.39M Mar 1, 2014 May 31, 2014 10-Q/A 2014-07-23
Q1 2014 -$923K -$172K +$72.6K +29.7% Dec 1, 2013 Feb 28, 2014 10-Q 2014-04-11
Q4 2013 -$995K -$255K +$527K +67.4% Sep 1, 2013 Nov 30, 2013 10-K 2015-03-03
Q3 2013 -$1.52M -$248K -$234K -1622% Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-20
Q2 2013 -$1.29M -$248K -$240K -2941% Mar 1, 2013 May 31, 2013 10-Q/A 2014-07-23
Q1 2013 -$1.05M -$244K -$389K -269% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-11
Q4 2012 -$660K -$782K Sep 1, 2012 Nov 30, 2012 10-K/A 2013-02-28
Q3 2012 -$14.4K Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-02
Q2 2012 -$8.16K -$10K -541% Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
Q1 2012 $144K +$135K +1496% Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-12
Q2 2011 $1.85K Mar 1, 2011 May 31, 2011 10-Q 2012-07-16
Q1 2011 $9.05K Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.